325 related articles for article (PubMed ID: 31930145)
1. Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography.
Chung YR; Kim YH; Ha SJ; Byeon HE; Cho CH; Kim JH; Lee K
J Diabetes Res; 2019; 2019():8164250. PubMed ID: 31930145
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
Kim M; Lee P; Kim Y; Yu SY; Kwak HW
Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008
[TBL] [Abstract][Full Text] [Related]
3. Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema.
Lee H; Jang H; Choi YA; Kim HC; Chung H
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):715-721. PubMed ID: 29392317
[TBL] [Abstract][Full Text] [Related]
4. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
Hwang HS; Chae JB; Kim JY; Kim DY
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
[TBL] [Abstract][Full Text] [Related]
5. A Pathogenetic Classification of Diabetic Macular Edema.
Parodi Battaglia M; Iacono P; Cascavilla M; Zucchiatti I; Bandello F
Ophthalmic Res; 2018; 60(1):23-28. PubMed ID: 29642065
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
7. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
8. Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema.
Srinivas S; Verma A; Nittala MG; Alagorie AR; Nassisi M; Gasperini J; Sadda SR
Am J Ophthalmol; 2020 Mar; 211():183-190. PubMed ID: 31758926
[TBL] [Abstract][Full Text] [Related]
9. Optical Coherence Tomography and Multifocal Electroretinography in Diabetic Macular Edema: A Neurovascular Relation With Vision.
Nagesh BN; Takkar B; Azad S; Azad R
Ophthalmic Surg Lasers Imaging Retina; 2016 Jul; 47(7):626-31. PubMed ID: 27434893
[TBL] [Abstract][Full Text] [Related]
10. Effects of Diabetic Macular Edema on Repeatability of Retinal Nerve Fiber Layer Thickness Measurements at the Macular and Peripapillary Area Using Swept-Source Optical Coherence Tomography.
Min JK; Lee S; Kim JS; Woo JM; Yang HS
Curr Eye Res; 2017 Feb; 42(2):307-314. PubMed ID: 27347610
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators in the vitreal reflux of patients with diabetic macular edema.
Cacciamani A; Esposito G; Scarinci F; Parravano M; Dinice L; Di Nicola M; Micera A
Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):187-197. PubMed ID: 30377797
[TBL] [Abstract][Full Text] [Related]
12. Types of diabetic macular edema assessed by optical coherence tomography.
Koleva-Georgieva DN; Sivkova NP
Folia Med (Plovdiv); 2008; 50(3):30-8. PubMed ID: 19009748
[TBL] [Abstract][Full Text] [Related]
13. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography findings predictive of response to treatment in diabetic macular edema.
Cho YJ; Lee DH; Kim M
J Int Med Res; 2018 Nov; 46(11):4455-4464. PubMed ID: 30259774
[TBL] [Abstract][Full Text] [Related]
15. Diabetic Macular Edema: Traditional and Novel Treatment.
Tomić M; Vrabec R; Poljičanin T; Ljubić S; Duvnjak L
Acta Clin Croat; 2017 Mar; 56(1):124-132. PubMed ID: 29120156
[TBL] [Abstract][Full Text] [Related]
16. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
18. Diabetic macular edema: an OCT-based classification.
Panozzo G; Parolini B; Gusson E; Mercanti A; Pinackatt S; Bertoldo G; Pignatto S
Semin Ophthalmol; 2004; 19(1-2):13-20. PubMed ID: 15658007
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography-based diabetic macula edema screening with artificial intelligence.
Hwang DK; Chou YB; Lin TC; Yang HY; Kao ZK; Kao CL; Yang YP; Chen SJ; Hsu CC; Jheng YC
J Chin Med Assoc; 2020 Nov; 83(11):1034-1038. PubMed ID: 32452907
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography in the diagnosis and management of diabetic macular edema: time-domain versus spectral-domain.
Schimel AM; Fisher YL; Flynn HW
Ophthalmic Surg Lasers Imaging; 2011 Jul; 42 Suppl():S41-55. PubMed ID: 21790110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
